---
figid: PMC2670105__zbc0240967280001
figlink: /pmc/articles/PMC2670105/figure/fig1/
number: F1
caption: IMP impedes Ras mitogenic signaling by limiting KSR1 complexes. In  the absence
  of mitogen, IMP blocks KSR1 C-terminal homo-oligomerization  (Step 1), KSR1-c-Raf
  binding (Step 2), B-Raf-MEK binding  without affecting their association with KSR1
  (Step 3), and  B-Raf-c-Raf hetero-oligomerization (Step 4). Upon stimulation,  Ras-GTP
  binds IMP and activates its autoubiquitination, thus relieving signal  inhibition.
  Concomitantly, Ras-GTP activates Raf and allows subsequent KSR1  complex formation
  and ERK pathway signaling.
pmcid: PMC2670105
papertitle: Signaling Threshold Regulation by the Ras Effector  IMP.
reftext: Sharon A. Matheny, et al. J Biol Chem. 2009 Apr 24;284(17):11007-11011.
pmc_ranked_result_index: '48679'
pathway_score: 0.942373
filename: zbc0240967280001.jpg
figtitle: IMP impedes Ras mitogenic signaling by limiting KSR1 complexes
year: '2009'
organisms: Homo sapiens
ndex: 0ea9914a-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2670105__zbc0240967280001.html
  '@type': Dataset
  description: IMP impedes Ras mitogenic signaling by limiting KSR1 complexes. In  the
    absence of mitogen, IMP blocks KSR1 C-terminal homo-oligomerization  (Step 1),
    KSR1-c-Raf binding (Step 2), B-Raf-MEK binding  without affecting their association
    with KSR1 (Step 3), and  B-Raf-c-Raf hetero-oligomerization (Step 4). Upon stimulation,  Ras-GTP
    binds IMP and activates its autoubiquitination, thus relieving signal  inhibition.
    Concomitantly, Ras-GTP activates Raf and allows subsequent KSR1  complex formation
    and ERK pathway signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - EGF
  - MAP2K2
  - KSR1
  - MAPK3
  - TRIP10
  - NRAS
  - BRAF
  - RAF1
  - MAP2K1
  - BRAP
  - KRAS
  - HRAS
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: -EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: KSR1
  symbol: KSR1
  source: hgnc_symbol
  hgnc_symbol: KSR1
  entrez: '8844'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STP
  symbol: STP
  source: hgnc_alias_symbol
  hgnc_symbol: TRIP10
  entrez: '9322'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: B-RAF)
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: IMP
  symbol: IMP
  source: hgnc_alias_symbol
  hgnc_symbol: BRAP
  entrez: '8315'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2670105__F1
redirect_from: /figures/PMC2670105__F1
figtype: Figure
---
